You can watch ATNFW and buy or sell other stocks, options, and ETFs commission-free!
180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.
Jim N. Woody, MD, PhD
Menlo Park, California
52 Week High
52 Week Low